- Advertisement -
A company promoting an intravenous form of cannabidiol (CBD) has been sent a warning letter from the U.S. Food and Drug Administration.
Cannabidiol is a non-intoxicating cannabinoid that is most commonly available in oral forms for ingestion.
According to the FDA, firm in question is marketing an…
